Warburg Pincus has agreed to acquire biotech business Polyplus-Transfection from European PE firm ArchiMed in a transaction that values the company at over $500 million, according to Bloomberg. Founded in 2001 and based in France, Polyplus develops and sells products that deliver nucleic acids for use in research, bioproduction and therapeutics.
Read the full article: Warburg Pincus Strikes Pact for Polyplus //
Source: https://pitchbook.com/newsletter/warburg-pincus-strikes-pact-for-polyplus